SRY -negative disorder of sex development in two biological brothers with SOX3 mutations
Journal of Pediatric Endocrinology and Diabetes · 09.04.2026 · 6 · 62-65
DOI: 10.25259/jped_76_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Endocrinology and Diabetes, online erschienen am 09.04.2026. Verfasst von Lucas Bradley Hooks und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
46,XX testicular disorder of sex development (DSD) is a rare condition most often caused by translocation of the SRY gene; however, sex-determining region Y ( SRY )-negative cases have been associated with SRY-box transcription factor 3 (SOX3) gene duplication. In this case report, the authors report two biological brothers with phenotypic male presentation who were both found to have a 46,XX karyotype, absence of SRY, and SOX3 duplication. Both presented with hypospadias and normal pubertal testosterone levels for age. These are the first reported familial cases of SRY -negative 46,XX testicular DSD caused by SOX3 duplication, supporting a potential heritable mechanism. Long-term follow-up is needed to determine fertility potential and gonadal tumor risk.
Zitieren
APA
Hooks, L. B., Hamilton, A., & Mercer, S. B. (2026). SRY -negative disorder of sex development in two biological brothers with SOX3 mutations. Journal of Pediatric Endocrinology and Diabetes, 6, 62-65. https://doi.org/10.25259/jped_76_2025
Vancouver
Hooks LB, Hamilton A, Mercer SB. SRY -negative disorder of sex development in two biological brothers with SOX3 mutations. Journal of Pediatric Endocrinology and Diabetes. 2026;6:62-65. doi:10.25259/jped_76_2025
BibTeX
@article{Hooks2026,
author = {Hooks, Lucas Bradley and Hamilton, Abby and Mercer, Shelly B.},
title = {SRY -negative disorder of sex development in two biological brothers with SOX3 mutations},
journal = {Journal of Pediatric Endocrinology and Diabetes},
year = {2026},
volume = {6},
pages = {62--65},
doi = {10.25259/jped_76_2025}
}
EUVIMED